COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases.

Authors :: Dalal RS
McClure E
Marcus J
Winter RW
Hamilton MJ
Allegretti JR
Source :: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 Aug; Vol. 19 (8), pp. 1730-1732.e2. Date of Electronic Publication: 2021 Feb 04.
Publication Year :: 2021
Abstract: Patients with inflammatory bowel disease (IBD) develop coronavirus disease 2019 (COVID-19) at similar rates as the general population, and there was initial concern regarding potential for severe illness. <superscript>1-4</superscript> Vaccinations were authorized for emergency use in the United States in December 2020 and aim to halt the spread of COVID-19. However, there are concerns that people will be hesitant to receive the vaccine for a variety of reasons including insufficient data in certain populations including those with IBD. We surveyed patients with IBD to identify potential concerns regarding COVID-19 vaccination.<br /> (Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.)

Subjects :: COVID-19 Vaccines
Humans
Perception
SARS-CoV-2
United States
Vaccination
COVID-19
Inflammatory Bowel Diseases

Language :: English
ISSN :: 1542-7714
Volume :: 19
Issue :: 8
Database :: MEDLINE
Journal :: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Publication Type :: Academic Journal
Accession number :: 33549869
Full Text :: https://doi.org/10.1016/j.cgh.2021.02.004

Full Text Access

Tools